Randomized phase 3 trial of irinotecan (CPT-11)+5FU/folinic acid (FA) vs CDDP+5FU in 1(st)-line advanced gastric cancer patients

Basit Öğe Kaydı
dc.contributor.authorDank, M
dc.contributor.authorZaluski, J
dc.contributor.authorBarone, C
dc.contributor.authorValvere, V
dc.contributor.authorPeschel, C
dc.contributor.authorWenczl, M
dc.contributor.authorGoker, E
dc.contributor.authorRisse, ML
dc.contributor.authorAwad, L
dc.contributor.authorBugat, R
dc.date.accessioned2019-10-27T18:57:41Z
dc.date.available2019-10-27T18:57:41Z
dc.date.issued2005
dc.departmentEge Üniversitesien_US
dc.description41st Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 13-17, 2005 -- Orlando, FLen_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.endpage308Sen_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16en_US
dc.identifier.startpage308Sen_US
dc.identifier.urihttps://hdl.handle.net/11454/37357
dc.identifier.volume23en_US
dc.identifier.wosWOS:000230326602054en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRandomized phase 3 trial of irinotecan (CPT-11)+5FU/folinic acid (FA) vs CDDP+5FU in 1(st)-line advanced gastric cancer patientsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu